Brock Lesnar and Jon “Bones” Jones each failed drug tests in relation to UFC 200, but neither fighter will be fined by UFC.
According to Marc Raimondi of MMA Fighting, UFC senior vice president of public relations Dave Sholler said any potential fines will instead be handed out by individual state athletic commissions.
Per Dave Doyle of MMA Fighting and multiple reports, Jones tested positive for Hydroxy-clomiphene and Letrozole metabolite, which led to him being pulled from the scheduled UFC 200 main event against Daniel Cormier.
Lesnar also tested positive for Hydroxy-clomiphene, according to Raimondi, but his results were not found until after he defeated Mark Hunt in a main-event heavyweight bout at UFC 200.
According to ESPN.com’s Brett Okamoto, Jones is under a temporary suspension levied by the Nevada State Athletic Commission until a formal decision regarding his status is reached.
Per Raimondi, the United States Anti-Doping Agency has the authority to definitively suspend Jones and Lesnar because of its partnership with the UFC.
Jones served a six-month suspension and was stripped of the light heavyweight title last year after his involvement in a hit-and-run accident in New Mexico.
The 29-year-old megastar was reinstated and scored an impressive victory over Ovince St. Preux in his return at UFC 197.
Jones’ positive test could lead to a two-year ban from competition, which means one of the UFC’s biggest draws may not return to the Octagon until 2018 at the earliest.
The same is true for Lesnar with regard to a potential suspension, but he has other options on the table since he doubles as a WWE Superstar.
UFC 200 marked Lesnar’s first fight since 2011, and while it could possibly be his last, Lesnar is set to face Randy Orton at WWE SummerSlam in August, and his lucrative sports entertainment career doesn’t figure to be impacted by the UFC issue.
Follow @MikeChiari on Twitter.
Read more MMA news on BleacherReport.com